Skip to content

The use of IV Tramadol (Contramal) versus immediate release Tramadol (Tradonal odis) in the postoperative period after knee surgery in a day surgery setting. A raondomised , open label

The use of IV Tramadol (Contramal) versus immediate release Tramadol (Tradonal odis) in the postoperative period after knee surgery in a day surgery setting. A raondomised , open label

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2007-006224-35-BE
Enrollment
60
Registered
2007-11-20
Start date
2007-12-11
Completion date
Unknown
Last updated
2022-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Male and female patients undergoing elective knee surgery in a day surgery setting.

Interventions

Trade Name: Contramal Pharmaceutical Form: Injection* INN or Proposed INN: TRAMADOL HYDROCHLORIDE CAS Number: 22204882 Concentration unit: mg/ml milligram(s)/millilitre Concentration type: equal Conce

Sponsors

University Hospitals Leuven
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: - Physical status ASA I-II-III - Patients aged 18 to 70 - elective knee arthroscopy in the day hospital centre; Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria: - ASA IV - History of PONV - The presence of known allergies to tramadol - Preoperative use of MAO's or opiods - Recent history of s

Design outcomes

Primary

MeasureTime frame
Main Objective: The primary objective of this study is to evaluate the postoperative analgesia after knee surgery povided by immediate release oral tramadol compared to intravenous tramadol.;Secondary Objective: The secondary objectives of this trial are to compare the two analgesic routes: - speed of effect - side effects - evaluation of patient satisfaction - time of discharge - to compare the total cost of both medications;Primary end point(s):

Countries

Belgium

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026